Antiviral Stockpiles for Pandemic Preparedness: Time for a Careful Rethink?



Associate Professor Nick Wilson and Professor Michael Baker

As part of influenza pandemic readiness, NZ has a 32 million dollar stockpile of flu virus - bestantiviral drugs. But given recent evidence from a new Cochrane systematic review – NZ policymakers should probably now carefully review this approach. This blog discusses some of the new evidence and suggests options for a review process. Continue reading